Calls under review
Horizon Europe Health Cluster and Cancer Mission
One-stage and two-stage 2025 calls evaluation results have been communicated. The deadline for full proposal submission of 2025 2-stage calls is 16 April 2026 (4.00 pm IST).
This is a two-stage joint transnational call entitled “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026)”. The pre-proposal submission deadline was 12 January 2026 at 13:00 GMT
European Rare Diseases Research Alliance (ERDERA) 2026
ERDERA’s 2026 Joint Transnational Call entitled “Resolving unsolved cases in rare genetic and nongenetic diseases through variant validation and new technological approaches” closed for pre-proposal submissions on of 12 February 2026.
Applications are currently undergoing national eligibility checks prior to proceeding to the next stage for evaluation.
Open Calls
Horizon Europe Health Cluster 2026 – 2027
The Horizon Europe Health Cluster 2026-2027 Work Programme is now published.
Horizon Europe Health Info Day for 2026 calls: Watch the morning sessions and afternoon sessions recordings
HE 2026 Single Stage call is currently open and will close on 16th April 2026. There are 18 call topics open for submission:
HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences (CSA)
HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research (CSA)
HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health (CSA)
HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens’ access to healthcare through integrated or personalised approaches (PPI)
HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine (IA)
HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices (CSA)
HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs) (CSA)
HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
EU Cancer Mission 2026 – 2027
The EU Cancer Mission 2026-2027 Work Programme is now published. Watch here the Cancer Mission 2026 Info Day.
2026 Single Stage call is currently open and will close on 15th Sept 2026. There are 7 call topics open for submission:
HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)
HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (CSA)
HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
EU4Health
EU4Health 2025 Work Programme – Open calls for Tender
HADEA/2025/OP/0052: Strengthening national implementation of organ transplant practices. Publication date 21 November 2025; deadline 27 February 2026; estimated value €2M.
EU Partnerships
European Rare Disease Research Alliance (ERDERA) Networking Support Scheme
The Networking Support Scheme (NSS) is a continuously open call designed to knit together researchers, clinicians and patient advocates working on rare diseases and rare cancers. Proposals may be lodged at any time with the next collection deadline on 7 April 2026 at 13:00. The first collection round is currently under assessment for applications submitted before 7 October 2025.
Under the scheme, applicants can request up to €30,000 per networking event to cover meeting costs, travel costs, hybrid-meeting platforms and other essentials. Rounds will be held every six months until April 2029 – or until the dedicated budget is exhausted – providing a response pathway for emerging collaborations of the partnership.
See our Grant updates story for information on Joint Transnational Calls funded through European Partnerships.
EDCTP3 2026 Work Programme
The Global Health EDCTP3 Work Programme 2026 is now published. Read to find opportunities for global health researchers.
Recording and presentations of the Global Health EDCTP3 Info Day 2026 and online networking can be found here.
Two-Stage Calls: Stage 1 submission deadline is the 4th March 2026 and full proposal deadline is the 17th September 2026. Topics include:
HORIZON-JU-GH-EDCTP3-2026-01-TB-01-two-stage: Global collaboration action for the development of TB drugs for therapy and chemoprophylaxis in adults and children in sub-Saharan Africa
HORIZON-JU-GH-EDCTP3-2026-01-LRTI-02-two-stage: Global collaboration action for prevention and treatment of Lower Respiratory Tract Infections (LRTIs) in sub-Saharan Africa
HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage: Global collaboration action towards better prevention, treatment and clinical management of HIV co-infections or co-morbidities in sub-Saharan Africa
HORIZON-JU-GH-EDCTP3-2026-02-CH-01-two-stage: Global collaboration action on climate and health in sub-Saharan Africa
One Stage Call. Full proposal deadline is on the 2nd of September 2026. Call topics include:
HORIZON-JU-GH-EDCTP3-2026-03-SERP-01: Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms
HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02: Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence.
Innovative Health Initiative (IHI)
IHI call 12 is a single stage applicant-drive call aligned with the IHI Strategic Research and Innovation Agenda. Deadline for full proposals: 21st April 2026
For full details of the topics, please, read the call text.
Upcoming Calls
EU4Health
The EU4Health 2025 Work Programme closed its calls for proposals in January 2026. The new EU4Health 2026 Work Programme is expected to be published later this year, after which new calls for proposals will be launched.
Calls for Tender
HADEA/2026/OP/0001: Implementation of the new SoHO regulation: training and networking of SoHO competent authorities’ staff for oversight. Publication date 3 March 2026; deadline 9 April 2026; estimated value €4,000.000.
Further calls for tenders are expected and will be published later in the year.
Horizon Europe Health Cluster 2026 – 2027
The Horizon Europe Health Cluster 2026-2027 Work Programme is now published.
2027 HE funding opportunities for researchers include:
2027 Single Stage – set 1 of 2027 calls: open on 10th February 2027 and close on 13th April 2027.
HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change (PCP)
HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
2027 Two-Stage calls – set 2 of 2027 calls: Frist stage opens on 10th February 2027 and closes on 13th April 2027. Second stage deadline is 22nd September 2027.
HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
HORIZON-HLTH-2027-02-DISEASE-14- two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases
HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable disease
HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics (IA)
2027 Single Stage calls – set 3 of 2027 calls: Calls open on 3rd June 2027 and close on 22nd Sept 2027.
HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine
HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
HORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcare (CSA)
EU Cancer Mission 2026 – 2027
The EU Cancer Mission 2026-2027 Work Programme is now published.
2027 opportunities for cancer researchers include:
2027 Single Stage calls. Calls open on 10th February 2027 and close on 21st Sept 2027 (not yet available in the EU Funding and Tenders portal).
HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to reveal novel targets for cancer treatment
HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers (IA)
HORIZON-MISS-2027-02-CANCER-03: Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multimodal treatment interventions for patients with rare or very rare cancers or cancer subtypes
HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
HORIZON-MISS-2027-02-CANCER-05: Precommercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines (PCP)
HORIZON-MISS-2027-02-CANCER-06: Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
See also the HRB website for general information on the Horizon Europe and EU4Health programmes.
